

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb60550</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Production of Egg Yolk Antibody (IgY) against Vibrio cholerae O1: Protective Effect in Mice</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Shoushtari</surname><given-names>Mohammad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Shooshtari</surname><given-names>Ali Barat</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Asadi</surname><given-names>Sepideh</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Karami</surname><given-names>Yousof</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Honari</surname><given-names>Mohsen</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Fathi</surname><given-names>Javad</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Zeinoddini</surname><given-names>Mehdi</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Alizadeh</surname><given-names>Ghorban Ali</given-names></name></contrib></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>15</volume>
      <issue>4</issue>
      <fpage>239</fpage>
      <lpage>244</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>5</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p style=&quot;text-align:left&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Cholera is an acute intestinal infection caused by &lt;em&gt;Vibrio cholera &lt;/em&gt;(&lt;em&gt;V. cholera&lt;/em&gt;). The development of antibodies against specific &lt;em&gt;V. cholerae &lt;/em&gt;may have a therapeutic effect. In the present research, we investigated the protective effect of egg yolk Immunoglobulin (IgY), which was produced by immunizing hens with formaldehyde-killed &lt;em&gt;V. cholerae&lt;/em&gt; O1 and subsequently the isolated IgY was orally administrated to the &lt;em&gt;V. cholerae&lt;/em&gt; O1 infected mice for evaluation of its immunizing capability. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:left&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;Methods:&lt;/strong&gt; In the current study, hens were immunized three times with&lt;strong&gt; &lt;/strong&gt;formaldehyde-killed &lt;em&gt;V. cholerae &lt;/em&gt;O1 (1.5&amp;times; 10&lt;sup&gt;7&lt;/sup&gt; &lt;em&gt;CFU/mL&lt;/em&gt;) and an equal volume of adjuvant. The IgY was isolated from egg yolk by polyethylene glycol method. The validity and activity of isolated IgY were confirmed with SDS-PAGE and ELISA methods, respectively. Subsequently IgY was orally administered to suckling mice following challenge with &lt;em&gt;V. cholerae&lt;/em&gt; O1.&lt;strong&gt; &lt;/strong&gt;ELISA results showed high antibody titer in the serum and egg yolk. Also, SDS-PAGE analysis showed successful purification of IgY and anti-&lt;em&gt;V.&lt;/em&gt; &lt;em&gt;cholerae&lt;/em&gt; IgY prevented the death of mice infected with &lt;em&gt;V.&lt;/em&gt; &lt;em&gt;cholerae &lt;/em&gt;O1. The anti-&lt;em&gt;V.&lt;/em&gt; &lt;em&gt;cholera&lt;/em&gt; IgY was administered at 2, 4, 6 hours&amp;rsquo; intervals after 3 hours of inoculation of mice with &lt;em&gt;V.&lt;/em&gt; &lt;em&gt;cholerae&lt;/em&gt; O1. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:left&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;Results:&lt;/strong&gt; Results showed that the rate of surviving mice (2 &lt;em&gt;mg/mL&lt;/em&gt; of IgY) were 60% after 4 hours and 40% after 6 hours and the rate of surviving mice (5 &lt;em&gt;mg/mL&lt;/em&gt; of IgY) was 70% after 4 hours and 60% after 6 hours. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:left&quot;&gt;&lt;span style=&quot;font-size:12pt&quot;&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; The findings suggested the egg yolk-driven IgY as a natural antibacterial protein, could be effective in the prevention and treatment of cholera disease.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
